BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34627251)

  • 21. Interventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma.
    Martí-Carvajal AJ; Cardona AF; Lawrence A
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005419. PubMed ID: 19588373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
    Li J; Gao JZ; Du JL; Wei LX
    World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of risk of non-Hodgkin's lymphoma with hepatitis B virus infection: a meta-analysis.
    Qi Z; Wang H; Gao G
    Int J Clin Exp Med; 2015; 8(12):22167-74. PubMed ID: 26885191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
    Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
    J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies.
    Matsuo K; Kusano A; Sugumar A; Nakamura S; Tajima K; Mueller NE
    Cancer Sci; 2004 Sep; 95(9):745-52. PubMed ID: 15471561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
    Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma.
    Desai SH; Baez-Sosa V; Hameed R; Al-Shbool G; Fernandez S; Vakiti A; Stingo F; Adhikari T; Paku E; Malkovska V; Fishbein D
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e185-e193. PubMed ID: 33132102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
    Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
    Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV.
    Besson C; Noel N; Lancar R; Prevot S; Algarte-Genin M; Rosenthal E; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Cheret A; Arvieux C; Katlama C; Salmon D; Boué F; Costello R; Hendel-Chavez H; Taoufik Y; Fontaine H; Coppo P; Mounier N; Delobel P; Costagliola D;
    AIDS; 2020 Mar; 34(4):599-608. PubMed ID: 31833850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.
    Marignani M; Fonzo Md; Begini P; Gigante E; Deli I; Pellicelli AM; Gallina S; de Santis E; Delle Fave G; Cox MC
    World J Gastrointest Pharmacol Ther; 2012 Apr; 3(2):21-8. PubMed ID: 22577616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies.
    Dal Maso L; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2078-85. PubMed ID: 17119031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of β2-microglobulin with the prognosis of non-Hodgkin's lymphoma: a meta analysis.
    Wang XL; Wang XL; He S; Zhai HL
    Int J Clin Exp Med; 2015; 8(3):3992-9. PubMed ID: 26064301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
    Gisbert JP; García-Buey L; Arranz R; Blas C; Pinilla I; Khorrami S; Acevedo A; Borque MJ; Pajares JM; Fernández-Rañada JM; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):135-8. PubMed ID: 15075985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
    Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
    Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and survival analysis of DICE regimen for 97 patients with relapsed or refractory Non-Hodgkin's lymphoma].
    Ping LY; Song YQ; Zheng W; Wang XP; Xie Y; Lin NJ; Tu MF; Ying ZT; Liu WP; Zhang C; Deng LJ; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):790-794. PubMed ID: 27719723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis-C Infection Incidence Among the non-Hodgkin's B-cell Lymphoma Patients in the Northeast of Iran.
    Aledavood SA; Ghavam-Nasiri MR; Ghaffarzadegan K; Raziee HR; Saboori G; Anvari K; Mohtashami S; Ahadi M; Memar B
    Iran J Cancer Prev; 2014; 7(3):147-51. PubMed ID: 25250166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
    Yang T; Hao L; Yang X; Luo C; Wang G; Lin Cai C; Qi S; Li Z
    BMJ Open; 2021 Sep; 11(9):e049123. PubMed ID: 34475167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
    Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
    J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.